Literature DB >> 24790797

Prescribing controlled substances during a prescription drug epidemic.

Anne M Pylkas1, Gavin Bart1.   

Abstract

We are currently in the midst of an epidemic of deaths caused by the misuse of prescription medications. Opioids, benzodiazepines, and stimulants are among the most frequently misused controlled substances and are integral to the neurologist's armamentarium. Thus, the decision to prescribe a controlled substance and how to mitigate the associated risks of their misuse is often vexing to the clinician. This installment in the "Clinical Challenge" series provides a basic narrative overview of the epidemiology of prescription drug misuse, a summary of each of the major classes of misused drugs, and clinical recommendations regarding screening for misuse and reducing the risks associated with prescribing controlled substances.

Entities:  

Year:  2014        PMID: 24790797      PMCID: PMC4001178          DOI: 10.1212/01.CPJ.0000437695.56006.4f

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  19 in total

1.  Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain.

Authors:  Jane M Liebschutz; Richard Saitz; Roger D Weiss; Tali Averbuch; Sonia Schwartz; Ellen C Meltzer; Elizabeth Claggett-Borne; Howard Cabral; Jeffrey H Samet
Journal:  J Pain       Date:  2010-03-24       Impact factor: 5.820

2.  Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey.

Authors:  Sean Esteban McCabe; John R Knight; Christian J Teter; Henry Wechsler
Journal:  Addiction       Date:  2005-01       Impact factor: 6.526

3.  Pharmaceutical overdose deaths, United States, 2010.

Authors:  Christopher M Jones; Karin A Mack; Leonard J Paulozzi
Journal:  JAMA       Date:  2013-02-20       Impact factor: 56.272

4.  Universal precautions in pain medicine: a rational approach to the treatment of chronic pain.

Authors:  Douglas L Gourlay; Howard A Heit; Abdulaziz Almahrezi
Journal:  Pain Med       Date:  2005 Mar-Apr       Impact factor: 3.750

5.  A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management.

Authors:  Todd M Moore; Ted Jones; Joe H Browder; Susan Daffron; Steven D Passik
Journal:  Pain Med       Date:  2009-11       Impact factor: 3.750

6.  CDC grand rounds: prescription drug overdoses - a U.S. epidemic.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-01-13       Impact factor: 17.586

7.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

8.  Impact of supervision of methadone consumption on deaths related to methadone overdose (1993-2008): analyses using OD4 index in England and Scotland.

Authors:  John Strang; Wayne Hall; Matt Hickman; Sheila M Bird
Journal:  BMJ       Date:  2010-09-16

9.  The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse.

Authors:  Nancy L Wiedemer; Paul S Harden; Isabelle O Arndt; Rollin M Gallagher
Journal:  Pain Med       Date:  2007 Oct-Nov       Impact factor: 3.750

10.  Patterns of abuse among unintentional pharmaceutical overdose fatalities.

Authors:  Aron J Hall; Joseph E Logan; Robin L Toblin; James A Kaplan; James C Kraner; Danae Bixler; Alex E Crosby; Leonard J Paulozzi
Journal:  JAMA       Date:  2008-12-10       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.